- Home
- PKOH vs ALT Comparison
PKOH vs ALT Comparison
Compare PKOH & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PKOH
- ALT
- Stock Information
- Founded
- PKOH 1907
- ALT 1997
- Country
- PKOH United States
- ALT United States
- Employees
- PKOH N/A
- ALT N/A
- Industry
- PKOH Industrial Specialties
- ALT Biotechnology: Pharmaceutical Preparations
- Sector
- PKOH Industrials
- ALT Health Care
- Exchange
- PKOH Nasdaq
- ALT Nasdaq
- Market Cap
- PKOH 397.8M
- ALT 457.0M
- IPO Year
- PKOH N/A
- ALT N/A
- Fundamental
- Price
- PKOH $32.19
- ALT $7.61
- Analyst Decision
- PKOH
- ALT Buy
- Analyst Count
- PKOH 0
- ALT 7
- Target Price
- PKOH N/A
- ALT $20.00
- AVG Volume (30 Days)
- PKOH 32.2K
- ALT 3.7M
- Earning Date
- PKOH 11-06-2024
- ALT 11-12-2024
- Dividend Yield
- PKOH 1.55%
- ALT N/A
- EPS Growth
- PKOH N/A
- ALT N/A
- EPS
- PKOH 1.29
- ALT N/A
- Revenue
- PKOH $1,657,100,000.00
- ALT $52,000.00
- Revenue This Year
- PKOH $3.93
- ALT N/A
- Revenue Next Year
- PKOH $4.64
- ALT N/A
- P/E Ratio
- PKOH $9.61
- ALT N/A
- Revenue Growth
- PKOH 0.31
- ALT N/A
- 52 Week Low
- PKOH $22.32
- ALT $2.38
- 52 Week High
- PKOH $34.50
- ALT $14.84
- Technical
- Relative Strength Index (RSI)
- PKOH 57.81
- ALT 52.04
- Support Level
- PKOH $32.34
- ALT $6.92
- Resistance Level
- PKOH $33.22
- ALT $11.16
- Average True Range (ATR)
- PKOH 1.24
- ALT 0.85
- MACD
- PKOH 0.28
- ALT 0.13
- Stochastic Oscillator
- PKOH 64.68
- ALT 24.63
About PKOH Park-Ohio Holdings Corp.
Park-Ohio Holdings Corp is a company, engaged in industrial supply chain logistics and diversified manufacturing business. It operates in three business segments namely Supply Technologies, Assembly Components and Engineered Products. Geographically, the business of the group is amplifying across the region of the United States, Asia, Europe, Canada, Mexico and others. The company derives most of the revenue from the Supply Technologies segment which provides the customer with total supply management services such as engineering and design support, supplier selection, quality assurance, barcoding, product packaging and tracking, just-in-time and point-of-use delivery and electronic billing services for a range of production components.
About ALT Altimmune Inc.
Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.